Intestinal injury owing to infl ammation, severe trauma, and burn is a leading cause of morbidity and mortality. Currently, animal models employed to study the intestinal response to injury and infl ammation depend on outdated methods of analysis. Given that these classic intestinal assays are lethal to the experimental animal, there is no ability to study the gut response to injury in the same animal over time. We postulated that by developing an in vivo assay to image intestinal injury using fl uorescent dye, it could complement other expensive, time-consuming, and semiquantitative classic means of detecting intestinal injury. We describe a novel in vivo, noninvasive method to image intestinal injury using a charge-coupled device (CCD) camera that allows for serial visual and quantitative analysis of intestinal injury. Our results correlate with traditional, time-consuming, semiquantitative assays of intestinal injury, now allowing the noninvasive, nonlethal assessment of injury over time.
Intestinal permeability assays are important in determining intestinal barrier function. These assays study permeability by measuring the movement of tracers from the intestinal lumen into the systemic circulation. The classic methods of determining intestinal injury have been used for decades and continue to give researchers valuable information about intestinal function. These methods do have several limitations in that they require sacrifi ce of the animal prior to harvest of tissues and subsequent time-intensive methods of analysis. Given that these classic intestinal assays are lethal to the experimental animal, there is no ability to study the gut response to injury in the same animal over time.
Advances in imaging techniques and the evolution of near-infrared fl uorescence have allowed for novel evaluations of the intestine following injury. Techniques such as magnetic resonance imaging and electron paramagnetic resonance spectroscopy have been used to monitor changes in the intestine following ischemia reperfusion. 11 , 12 Nearinfrared spectroscopy is another method that has recently been used to study in vivo changes in gut pH and image the presence of cellular damage using models of intestinal injury. 13 , 14 Fluorescent proteins or near-infrared quantum dots can be bound to molecules of interest and tracked using fl uorescence imaging techniques, serving as a biomarker based on the distribution of fl uorescence signal. 15 , 16 As technology has progressed, the goal of developing an assay that allows for a relatively inexpensive, rapid screening of intestinal injury has become attainable.
A LTHOUGH NEAR-INFRARED IMAGING is increas-
ingly being used to monitor diverse biologic conditions, it has never been applied to quantify the intestinal response to disease. 1 , 2 Regardless of its etiology, numerous medical conditions, including infl ammatory bowel disease, 3 necrotizing enterocolitis, 4 sepsis, 5 enteritis, 6 liver disease, 7 burn, 8 and trauma, 9 result in tight junction breakdown and increased intestinal epithelial permeability. Paracellular permeability and translocation of pathogens from within the gastrointestinal tract can result in an intestinal infl ammatory response, characterized by proinfl ammatory cytokine synthesis. Intestinal barrier injury is an important inciting event that can result in the systemic infl ammatory response, which is seen after severe injury. 10 Translational research efforts studying the intestinal infl ammatory response allow these clinical observations to be studied in the laboratory, where we rely on animal models to understand the gut response to injury. Current methods for studying intestinal injury include histology, immunohistochemistry, immunoblotting, and cytokine analysis.
The inability to easily, quickly, and effectively measure intestinal injury in animal models has limited our capacity to monitor the gut response to injury and the effects of candidate therapeutics. To this end, we postulated that by developing an in vivo assay to image intestinal injury using fl uorescent dye, it could be an ideal alternative evaluation strategy with several advantages over other expensive, timeconsuming, and semiquantitative classic means of detecting intestinal injury.
Materials and Methods

Burn Model
Male BALB/c mice weighing 20 to 24 g were purchased from Jackson Laboratory (Sacramento, CA). Animals were placed in a 12-hour light/dark cycle and provided with food and water ad libitum. Prior to the experiment, animals were anesthetized with inhaled isofl urane. The dorsal fur was removed using an electronic clipper. Animals were placed in a template estimating 30% total body surface area (TBSA). While under anesthesia, animals were subjected to a 7-second dorsal steam burn. Immediately following burn, animals were given a subcutaneous injection of 1.5 mL normal saline with buprenorphine in a nonburned area. Animals were returned to their cages to recover from anesthesia. Sham animals underwent general anesthesia, dorsal fur clipping, and injection of normal saline with buprenorphine but were not burned.
These experiments were approved by the University of California Animal Subjects Committee and are in accordance with guidelines established by the National Institutes for Health.
Intestinal Permeability Assay to 4 kDa FITC-Dextran
Animals ( n ³ 5 per group) were anesthetized with inhaled isofl urane and a midline laparotomy was performed. A 5 cm segment of distal ileum was isolated between silk ties. An intraluminal injection of 5 mg fl uorescein isothiocyanate (FITC)-dextran (4 kDa, Sigma, St. Louis, MO) in 200 µL phosphate-buffered saline (PBS) was performed at various time points following burn. The abdominal wall was closed following administration of FITC-dextran. Thirty minutes following intraluminal injection, blood was obtained via cardiac puncture and placed in heparinized Eppendorf tubes on ice. Blood was centrifuged at 10,000 g for 10 minutes, and the plasma was removed. The plasma was then analyzed for the concentration of FITC-dextran using a SpectraMax M5 fl uorescence spectrophotometer (Molecular Devices, Sunnyvale, CA). A standard curve was obtained by diluting serial concentrations of FITC-dextran in mouse serum.
Intestinal Permeability to Increasing Size FITC-Dextran
Animals ( n ³ 3 per group) were anesthetized 4 hours following burn injury. Laparotomy and isolation of the distal ileum were performed prior to intraluminal injection of 5 mg of either 20 or 70 kDa FITC-dextran (Sigma) in 200 µL PBS. Cardiac puncture was performed 30 minutes after intraluminal injection as previously described. Plasma was obtained for measurement in a SpectraMax M5 fl uorescence spectrophotometer (Molecular Devices). A standard curve was obtained by diluting serial concentrations of each molecular-weight FITC-dextran in mouse plasma.
Histologic Evaluation
Animals ( n = 3 per group) were sacrifi ced at several time points following burn for excision of the distal ileum for histologic evaluation. Specimens were stored in 10% PBS buffered formalin and embedded in paraffi n blocks. Sections of distal ileum were cut 7 mm thick and placed onto glass slides. Specimens were stained with hematoxylin and eosin for imaging using an Olympus IX70 light microscope (Olympus, Center Valley, PA) at ×200 magnifi cation. Images were obtained using Q-imaging software (Surrey, BC). Histologic gut injury was scored and reviewed by a pathologist blinded to the experimental groups. Three randomly selected fi elds from each specimen were graded based on a scoring system characterizing gut injury on a scale from 0 to 4: 0 = normal; no damage; 1 = mild; focal epithelial edema and necrosis; 2 = moderate; diffuse swelling or necrosis of the villi; 3 = severe; diffuse necrosis of the villi with evidence of neutrophil infi ltration in the submucosa; 4 = major; widespread necrosis with massive neutrophil infi ltration and hemorrhage as previously described. 17
Fluorescence Imaging
Animals ( n ³ 3 per group) were anesthetized with inhaled isofl urane. A midline laparotomy was performed, and a 5 cm segment of distal ileum was isolated between silk ties. An injection of 5 mg FITC-dextran (4 kDa) or 1 µg Alexa Fluor 680 (3 kDa, Invitrogen, Carlsbad, CA) in 200 µL PBS was performed into the lumen of the isolated intestine. The abdominal wall was then closed with silk sutures. The animal was maintained under general anesthesia following the procedure. Thirty minutes following intraluminal injection of fl uorescent tracer, the animal was placed in the Xenogen IVIS Lumina (Caliper LifeSciences, Hopkinton, MA) imaging system. Images were obtained with identical camera settings using Living Images 3.0 software (Caliper LifeSciences). Animal images were obtained using the Cy5.5 fi lter (Alexa Fluor 680) or the green fl uorescent protein (GFP) fi lter (FITC) with 1-second exposure, f-stop of 1, from fi eld of view C. Images of the excised intestinal segments were obtained using identical settings; however, they were imaged at fi eld of view B. Quantifi cation of fl uorescence image was obtained by measuring the fl uorescence within an equivalent region of interest for each animal using the Living Images software. Data are expressed as fl uorescent intensity (arbitrary units) ± the standard error of the mean (SEM).
Gavage of Near-Infrared Tracer
With the animal under general anesthesia, a gavage was performed using PE-90 polyethylene tubing (Becton-Dickinson, Franklin Lakes, NJ). A 1 mL solution containing 5 µg of Alexa Fluor 680 was instilled into the stomach and small intestine ( n = 4 animals per group). Serial images were obtained using the Xenogen IVIS Lumina imaging system with Living Images 3.0 software. To account for differences in the delivery of fl uorescent dye into the gastrointestinal tract following gavage, data are represented as the decrease in fl uorescent intensity seen from the same animal over the imaging time course. Relative fl uorescent intensity was obtained by dividing the abdominal fl uorescence obtained at each time point by the initial abdominal fl uorescence obtained from that same animal immediately following gavage (time = 0).
Treatment with Pentoxifylline
To assess the ability of in vivo fl uorescent imaging to detect changes in intestinal injury following therapeutic interventions, animals were treated with the antiinfl ammatory drug pentoxifylline (PTX; 1-[5-oxohexyl]-3,7-dimethylxanthine, Sigma). Immediately following 30% TBSA burn, animals underwent an intraperitoneal injection of 12.5 mg/kg PTX dissolved in normal saline ( n = 6 animals) as previously described. 8 , 18 Animals were returned to their cage until 4 hours following burn injury, at which time they underwent gavage of Alexa 680 and serial imaging in the Xenogen IVIS Lumina.
Statistical Analysis
Data are expressed as the mean ± SEM. Statistical signifi cance for gut injury scoring was performed using the Kruskal-Wallis test for nonparametric data with a post hoc Mann-Whitney test performed in pairwise fashion. The statistical signifi cance among groups for the remainder of the experiments was determined using t -test or analysis of variance with Bonferroni correction where appropriate. Statistical analysis was performed using SPS S software v11.5 (SPSS, Chicago, IL). Statistical signifi cance was defi ned as p < .05.
Results
Intestinal Permeability to FITC-Dextran
As molecular weight is known to affect paracellular permeability, 19 we investigated intestinal permeability to 4, 20, and 70 kDa FITC-dextran at 4 hours following severe burn ( Figure 1A ). Whereas intestinal permeability to 4 kDa FITCdextran was elevated, larger-size FITC-dextran (20, 70 kDa) showed decreased ability to leave the intestinal lumen and enter the systemic circulation. The kinetics of burn-induced intestinal permeability to 4 kDa FITC-dextran was also examined. Intestinal permeability to 4 kDa FITC-dextran peaks at 4 hours following severe burn and returns to baseline at 24 hours ( Figure 1B ).
Histologic Intestinal Injury
Segments of distal ileum collected 4 hours following burn exhibited evidence of histologic gut injury as characterized by blunting of villi ( Figure 1C ). In contrast, sections of intestine from sham animals and animals at 2 and 24 hours following burn lacked histologic evidence of injury. In spite of increased permeability at 2 hours following burn, histologic evidence of injury lags behind the ability to detect changes in permeability. Histologic specimens were reviewed by a pathologist blinded to the experimental conditions and scored in three randomly selected regions on a scale from 0 (normal) to 4 (major; widespread necrosis with massive neutrophil infi ltration). Maximal gut injury was seen at 6 hours following burn (2.67 ± 0.19). This was signifi cantly higher than gut injury scores seen at 2 hours (1.33 ± 0.19, p < .05) and 24 hours (1.67 ± 0.33, p = .05) following injury.
Fluorescent Imaging of Intestinal Injury Using FITC-Dextran
A deep-cooled charge-coupled device (CCD)-based imaging system (Xenogen IVIS Lumina) was used to monitor changes in intestinal integrity following burn injury ( Figure 2 ). Using FITC as a fl uorescent dye for minimally invasive imaging led to a signifi cant amount of quenching, demonstrated by disappearance of intestinal fl uorescent signal when the abdominal wall is closed over the injected intestinal segment. The fact that the fl uorescence signal from burned animals overcomes this quenching allows us to exploit this difference to detect intestinal injury in burned animals.
Near-Infrared Imaging of Intestinal Injury
To improve our image sensitivity and decrease the effects of quenching, we employed the near-infrared dye Alexa Fluor 680. The CCD camera was used to obtain images of near-infrared fl uorescence using intraluminal Alexa 680 at several time points following severe burn ( Figure 3A ) . Images indicate a plateau in fl uorescence from animals at 4 to 6 hours following burn, with decreased fl uorescence seen at later time points. These visual changes in fl uorescence were confi rmed by quantifi cation of the fl uorescent signal from all animals imaged at each time point ( Figure 3C ). 
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Intestinal segments were harvested en bloc to assess ex vivo fl uorescence ( Figure 3B ). There is still evidence of quenching, and although it appears minimal, the quantifi cation of the fl uorescent signal is higher in the excised intestine ( Figure 3D ). The pattern of fl uorescence imaging of the excised intestine across the time course is similar to the in vivo images, with increased fl uorescence at 4 to 6 hours following burn. Noninjured animals that did not undergo injection of fl uorescent dye were imaged to assess background fl uorescence levels (data not shown). Some background fl uorescence was noted within the intestinal lumen, likely from residual chow. The amount of background intestinal fl uorescence was minimal and is no longer visualized after the adjustment of the standardized color bar settings used in these images.
Etiology of Increased Fluorescence in Animals with Intestinal Injury
We were then interested in determining the etiology of the changes in fl uorescent signal between animals in each experimental group. We hypothesized that uninjured intestine was able to clear the fl uorescent dye during the 30-minute assay while the injured intestine, perceivably owing to either decreased villous height or compromised perfusion, had decreased clearance of the near-infrared dye. Imaging was obtained immediately after intraluminal injection of dye to control for the effects of clearance. When comparing sham animals and animals 4 hours following severe burn, we found no difference in fl uorescent signal between groups when imaging the abdomen or the resected intestine ( Figure 4A ) Figure 4B ) or intestinal fl uorescence ( Figure 4C ) between sham and burned animals.
Noninvasive Imaging of Intestinal Injury
To demonstrate that this method of imaging intestinal injury could be performed in a noninvasive fashion, animals were given a gavage of Alexa Fluor 680 prior to imaging. A time course of images was obtained in the same animal over the fi rst 60 minutes after gavage of Alexa 680 to evaluate changes in fl uorescence ( Figure 5A ). In sham animals, fl uorescence decreases substantially over the 60-minute imaging sequence. Fluorescence decreases to a lesser degree over this time course in the burned animals, resulting in differential fl uorescence between sham and burned animals. Next, we examined the differences in fl uorescent signal dissipation over the imaging time course between animals 4 hours following burn and sham animals ( Figure 5B ). We measured the relative decrease in fl uorescent signal from each animal by comparing the fl uorescent intensity measured at each time point with the fl uorescence measured immediately after gavage (time = 0). Fluorescent signal dissipates at a greater rate from the abdomen of the sham animal compared with the burned animal. We are able to exploit the different rates of signal decrease to obtain differential imaging and quantifi cation of fl uorescence between sham and burned animals. This difference becomes most evident at 20 and 30 minutes following gavage of near-infrared dye, suggesting that these are the ideal time points to use this imaging technique as a marker for intestinal injury.
Assessing Therapeutics Using Noninvasive Imaging of Intestinal Injury
The true utility of in vivo, near-infrared imaging of gut injury lies in its ability to monitor the effects of candidate therapeutics on intestinal injury. To assess the ability of this assay to detect modulation of gut injury following severe burn, we treated animals with the nonspecifi c phosphodiesterase inhibitor PTX immediately following injury. PTX has been shown to have signifi cant antiinfl ammatory properties in models of sepsis, 20 hemorrhagic shock, 21 and pancreatitis. 22 We recently studied the effects of PTX on intestinal barrier injury using this burn model, fi nding that a single dose of PTX immediately following burn decreases histologic gut injury, attenuates intestinal infl ammation, and improves intestinal barrier integrity to 4 kDa FITC-dextran. 8 , 18 Burned animals treated with PTX underwent gavage of Alexa 680 at 4 hours following injury. Serial fl uorescent imaging was then obtained at multiple time points following gavage, allowing for the comparison of changes in relative fl uorescent intensity from the abdomen of all animals imaged ( Figure 6 ). Compared to burn alone, abdominal fl uorescence was signifi cantly decreased in burned animals treated with PTX following gavage of Alexa 680 when quantifying fl uorescence at the 30-minute imaging time point. There was no difference in relative fl uorescent intensity when comparing sham and burned animals treated with PTX.
Discussion
In this series of experiments, we demonstrated a novel method for the in vivo imaging of intestinal injury using near-infrared dye, which correlated with classic assays of intestinal injury including histology and intestinal permeability assays. We performed a 30% TBSA full-thickness steam burn on male BALB/c mice, an injury that is known to induce systemic infl ammation, cause histologic gut injury, and increase intestinal permeability. 18 We fi rst validated our model by examining changes in intestinal permeability to increasing molecular-weight FITC-dextran. Our injury model resulted in increased permeability to 4 kDa FITCdextran. Permeability decreased as the molecular weight of FITC-dextran increased, with minimal permeability to 20 and 70 kDa probes. The results of this assay focused our subsequent studies on 4 kDa molecular weight. We then We then developed a technique for determining intestinal injury by imaging intraluminal fl uorescent dye with a Xenogen IVIS Lumina. The Xenogen system uses a CCD camera to perform imaging of both fl uorescence and luminescence. We initially imaged animals following injection of FITC-dextran; however, there was signifi cant quenching of the fl uorescent signal at this wavelength caused by the overlying abdominal wall. This necessitated our transition to imaging with nearinfrared dye. At several time points following injury, animals underwent laparotomy and intraluminal injection of the near-infrared dye Alexa Fluor 680. Imaging was obtained 30 minutes following intraluminal injection. By performing imaging and quantifi cation of the fl uorescent intensity, we fi nd a plateau in fl uorescent signal at 4 to 6 hours following burn. This fl uorescence decreases at later time points, suggesting either a decrease in intestinal injury or barrier recovery. The results of these images correlated with the classic assays (intestinal permeability to FITC-dextran, histology) that were performed and show maximal intestinal injury at 4 to 6 hours after injury, returning to baseline at 24 hours.
We then determined the explanation for our ability to measure increased fl uorescence from the injured gut because each animal receives the same concentration of dye delivered to an equivalent length of gut. We hypothesized that the injured gut had decreased ability to clear the intraluminal dye during the 30-minute period between intraluminal injection and imaging. We postulated that this may be due to the decreased villous height that is known to exist in the injured intestine or decreased perfusion to the gut following injury. To test this hypothesis, we obtained imaging immediately following intraluminal injection of dye, leaving no time for clearance of dye in either group. These images showed both visually and quantitatively that there was no difference in fl uorescence between the injured and the uninjured gut. These results supported the notion that the increased fl uorescent signal seen at 4 and 6 hours following burn injury is due to the inability of the injured intestine to clear the intraluminal fl uorescent marker over the 30 minutes of the assay. The differential ability to clear the fl uorescent marker from the intestine results in the differential appearance of the injured and uninjured intestine. Therefore, this technique allows for in vivo imaging of intestinal injury using intraluminal placement of a near-infrared tracer.
Because the assessment of intestinal injury in a completely noninvasive fashion is clearly ideal, we developed a method to deliver the near-infrared dye using gavage rather than laparotomy. Animals were given a gavage of Alexa Fluor 680 to monitor gut barrier integrity. We compared the changes Figure 6 . Treatment with an antiinfl ammatory drug decreases abdominal fl uorescence following injury. Animals ( n = 6) were treated with the phosphodiesterase inhibitor pentoxifylline (PTX; 12.5 mg/kg intraperitoneally) immediately after severe burn injury. Four hours following injury, animals were given a gavage of the near-infrared dye Alexa 680. In vivo, serial fl uorescent imaging was obtained in the Xenogen IVIS Lumina. A , Representative images of animals from each experimental group obtained 30 minutes after gavage. B , Relative fl uorescent intensity was calculated by dividing the fl uorescent intensity at each time point by the fl uorescent intensity measured immediately following gavage (t = 0). The mean relative fl uorescent intensity ± SEM is shown for each group from images obtained at 20, 30, and 40 minutes following gavage of near-infrared dye. Relative fl uorescent intensity is decreased from the abdomen of burned animals treated with PTX compared with animals subjected to burn alone. * p < .05 versus sham; ** p = .01 versus sham; † p = .05 versus burn; # p < .01 versus burn using analysis of variance. imaging chamber. Technology certainly exists to perform imaging and measurement of fl uorescence in a sensitive manner. Further studies would also be needed to understand the ideal volume of fl uorescent dye that would need to be delivered to the gut as the size of the subject increases. In the future, performing in vivo studies of gut barrier injury in human subjects could certainly enhance our understanding of numerous pathologies altering gut barrier function.
Clearly, studies will need to be undertaken to identify safe and effective means of delivering near-infrared fl uorescent dye to the intestine of human subjects. The ability to perform rapid, serial, in vivo assessments of intestinal injury using near-infrared fl uorescent imaging could be ideal for use in burn research and have great utility in models of infl ammatory bowel disease, intestinal ischemia, and other conditions causing signifi cant gut injury. First, the results to date correlate well with other markers of intestinal injury using more classic means of evaluation, including intestinal permeability assays, microscopic evaluations, and changes in markers of serum and intestinal infl ammation (tumor necrosis factor-a) measured in other studies we have published using this model. 8 Second, near-infrared fl uorescent imaging allows for a serial visual and quantitative evaluation of intestinal injury that can be used to evaluate intestinal injury in models of infl ammation, shock, and infl ammatory bowel disease. The ability to perform this in vivo assay in a noninvasive fashion allows for the imaging of the intestine over time in the same animal. Importantly, given that this imaging technique is not lethal, the number of animals required to complete these investigations could be reduced. This method of in vivo near-infrared imaging of intestinal injury complements classic assays of intestinal damage and may facilitate the monitoring of these important biologic changes and allow for the screening of candidate therapeutics with relative ease. in fl uorescent image between sham animals and animals 4 hours following severe burn and demonstrated our ability to adequately deliver and image the fl uorescent dye with success similar to that using laparotomy followed by intraluminal injection. When the fl uorescent image was followed serially in the same animal over time, there was increased fl uorescent signal in animals 4 hours following burn compared with sham animals, which correlates with our previous results. The quantifi cation of fl uorescence from gavaged animals shows increased fl uorescent intensity following burn. This demonstrates our ability to perform this assay in a noninvasive fashion, which will allow the assessment of intestinal injury in the same animal over minutes, hours, or days.
The true utility of this method for in vivo fl uorescent imaging lies in its ability to quickly and easily assess the effects of therapeutics aimed at limiting intestinal injury following various insults. To demonstrate the ability of this assay to detect the attenuation of gut injury following burn, we treated a group of animals with the nonspecifi c phosphodiesterase inhibitor PTX immediately following burn insult. We chose PTX based on the extensive studies that have been conducted in our laboratory characterizing the antiinfl ammatory effects of PTX in various injury models. [23] [24] [25] [26] We recently published data demonstrating the protective effects of PTX on intestinal injury using this burn model. Specifi cally, we showed that treatment with PTX attenuates burn-induced intestinal permeability at the same 4-hour time point used in the gavage experiments performed in this study. 8 We also demonstrated the ability of PTX to decrease histologic gut injury, modulate intestinal tight junction protein expression, and attenuate markers of intestinal infl ammation, including activation of the nuclear factor kB signaling cascade. 18 We demonstrated decreased fl uorescent intensity from the abdomen of burned animals treated with PTX compared with sham animals using images obtained following gavage of near-infrared dye. Serial imaging once again suggests that imaging 30 minutes after gavage of near-infrared dye is the ideal time point for quantifi cation of relative fl uorescent intensity. This series of experiments confi rms the ability of this assay to image and quantitatively measure modulation of intestinal injury following severe burn. The advantage of this assay over classic means of detecting intestinal injury clearly lies in the relative ease it takes to obtain these results using this real-time, in vivo technique.
Ideally, this imaging technique could be used in the future to measure gut barrier injury in large animal models. This current series of experiments uses the Xenogen IVIS Lumina imaging system to measure intestinal fl uorescence, which limits the size of animal that can be placed in the
